Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.53B -18.5%
Revenue (ttm)	1.91B +26.4%
Net Income	115.99M +31.0%
EPS	1.40 +32.1%
Shares Out	n/a
PE Ratio	30.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,291
Average Volume	623,240
Open	41.50
Previous Close	42.37
Day's Range	41.50 - 42.79
52-Week Range	30.22 - 60.74
Beta	0.40
RSI	59.71
Earnings Date	May 30, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.